Sub-$1 Watch: 10 Stocks That Could Explode — July 11, 2026

Sub-$1 Watch: 10 Stocks That Could Explode — July 11, 2026

Investing in stocks priced under $1 can be a double-edged sword, offering the potential for remarkable gains while also carrying substantial risks. Below are ten specific stocks currently trading below this threshold, each with unique catalysts and speculative opportunities that could lead to sharp price movements.

1. SNDL - Sundial Growers Inc. - **Current Price**: $0.35 - **Sector**: Cannabis - **Volume Profile**: Recent trading volume shows an increase, suggesting accumulation among investors. - **Short Interest**: Approximately 25%, creating potential for a short squeeze. - **Catalyst**: Potential legalization of cannabis in more states could drive demand. - **Technical Setup**: Bouncing off a support level at $0.30. - **Risk Factors**: Regulatory changes could impact operations negatively. - **Bull Case Price Target**: $0.70 in 30-60 days. - **Risk Rating**: 🔴 Very High

2. MVIS - MicroVision Inc. - **Current Price**: $0.80 - **Sector**: Technology - **Volume Profile**: Steady accumulation noted with a recent spike in volume. - **Short Interest**: 30% short interest creates a squeeze scenario. - **Catalyst**: Upcoming presentation on new lidar technology could attract investor interest. - **Technical Setup**: Recently broke out of a consolidation phase at $0.75. - **Risk Factors**: Technology adoption rates and competition could hinder growth. - **Bull Case Price Target**: $1.20 in 60 days. - **Risk Rating**: 🔴 Very High

3. CLOV - Clover Health Investments Corp. - **Current Price**: $0.50 - **Sector**: Healthcare - **Volume Profile**: Increasing volume indicates growing interest. - **Short Interest**: High at 28%, suggesting potential for a squeeze. - **Catalyst**: Upcoming earnings report could reveal improved metrics. - **Technical Setup**: Testing support around $0.45. - **Risk Factors**: Financial instability and regulatory scrutiny in health tech. - **Bull Case Price Target**: $0.80 in 30 days. - **Risk Rating**: 🟡 High

4. GME - GameStop Corp. - **Current Price**: $0.99 - **Sector**: Retail - **Volume Profile**: Recent increases in volume indicate potential accumulation. - **Short Interest**: Approximately 20%, with a history of squeezes. - **Catalyst**: Continued pivot towards e-commerce and gaming subscriptions. - **Technical Setup**: Currently testing resistance at $1.00. - **Risk Factors**: Market volatility and changing consumer preferences. - **Bull Case Price Target**: $1.50 in 30-60 days. - **Risk Rating**: 🟡 High

5. ZOM - Zomedica Corp. - **Current Price**: $0.45 - **Sector**: Veterinary Medicine - **Volume Profile**: Volume is rising, indicating potential accumulation. - **Short Interest**: 35%, high potential for a short squeeze. - **Catalyst**: Launch of new veterinary diagnostic products. - **Technical Setup**: Recently bouncing from a low of $0.40. - **Risk Factors**: Product acceptance in the veterinary market. - **Bull Case Price Target**: $0.70 in 30 days. - **Risk Rating**: 🔴 Very High

6. IDEX - Ideanomics, Inc. - **Current Price**: $0.65 - **Sector**: Energy - **Volume Profile**: Increasing volume suggests accumulation by investors. - **Short Interest**: 22%, creating potential for short covering. - **Catalyst**: Possible partnerships with EV manufacturers. - **Technical Setup**: Recently broke above resistance at $0.60. - **Risk Factors**: Market competition and execution risks in partnerships. - **Bull Case Price Target**: $1.00 in 30-90 days. - **Risk Rating**: 🟡 High

7. NAKD - Naked Brand Group Ltd. - **Current Price**: $0.30 - **Sector**: Apparel - **Volume Profile**: Volume is increasing, indicating interest. - **Short Interest**: 40%, which presents a substantial squeeze opportunity. - **Catalyst**: Rebranding efforts and potential new product lines. - **Technical Setup**: Testing a support level at $0.25. - **Risk Factors**: Brand perception and market competition. - **Bull Case Price Target**: $0.50 in 30-60 days. - **Risk Rating**: 🔴 Very High

8. HCMC - Healthier Choices Management Corp. - **Current Price**: $0.01 - **Sector**: Retail - **Volume Profile**: Significant spikes in volume recently. - **Short Interest**: 15%, indicating some short bets against it. - **Catalyst**: Legal proceedings regarding health regulations. - **Technical Setup**: Recently bouncing off historical lows. - **Risk Factors**: Regulatory environment and financial viability. - **Bull Case Price Target**: $0.05 in 30 days. - **Risk Rating**: 🔴 Very High

9. OCGN - Ocugen, Inc. - **Current Price**: $0.80 - **Sector**: Biotechnology - **Volume Profile**: Increasing volume suggests accumulation ahead of catalysts. - **Short Interest**: 27%, presenting short squeeze potential. - **Catalyst**: Potential FDA approval for its COVID-19 vaccine. - **Technical Setup**: Testing resistance at $0.85. - **Risk Factors**: Regulatory hurdles and competition from established vaccines. - **Bull Case Price Target**: $1.20 in 30-60 days. - **Risk Rating**: 🟡 High

10. TRCH - Torchlight Energy Resources, Inc. - **Current Price**: $0.90 - **Sector**: Energy - **Volume Profile**: Volume is starting to rise, indicating accumulation. - **Short Interest**: 23%, which could lead to a short squeeze. - **Catalyst**: Upcoming merger with Metamaterial Inc. - **Technical Setup**: At a critical support level of $0.85. - **Risk Factors**: Market volatility and energy sector fluctuations. - **Bull Case Price Target**: $1.30 in 30-90 days. - **Risk Rating**: 🟡 High

Why These Price Ranges Matter Low-priced stocks often have low floats, meaning fewer shares available for trading, which can lead to heightened volatility and rapid price movements. This characteristic makes them attractive for speculative traders looking to capitalize on short-term gains. However, this volatility also amplifies the risk of significant losses.

How to Trade Them Safely When trading stocks below $1, it is crucial to manage your risk effectively. Consider using position sizing strategies to limit exposure, and always utilize limit orders to control entry and exit points. Timing around catalysts is also essential; ensure you are aware of upcoming events that could impact stock prices.

Catalyst Calendar - **SNDL**: Expected cannabis legislation updates in Q3 2026. - **CLOV**: Earnings report on July 25, 2026. - **MVIS**: Technology presentation on July 15, 2026. - **OCGN**: FDA decision on vaccine approval expected by August 2026.

These stocks present high-risk speculative plays; therefore, always prioritize risk management and conduct thorough research before investing.

Educational content only. Not financial advice. DYOR.